Norris Perne & French’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-377,045
Closed -$10.5M 140
2022
Q4
$10.5M Sell
377,045
-30,649
-8% -$784K 1.04% 46
2022
Q3
$9.54M Sell
407,694
-80,181
-16% -$2.42M 0.99% 48
2022
Q2
$16.5M Buy
487,875
+4,761
+1% +$167K 1.58% 25
2022
Q1
$16.9M Buy
483,114
+3,255
+0.7% +$111K 1.36% 34
2021
Q4
$14.6M Buy
479,859
+12,194
+3% +$397K 1.13% 44
2021
Q3
$15.3M Buy
467,665
+225,925
+93% +$7.23M 1.32% 34
2021
Q2
$7.32M Buy
+241,740
New +$7.96M 0.63% 67

Other funds holding OGN

Norris Perne & French's OGN Position: Q1 2023 in Review

Norris Perne & French sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 377,045 shares — an estimated $10.5M sold.

Norris Perne & French first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $16.9M in Q1 2022. 768 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Norris Perne & French reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Norris Perne & French sold 377,045 Organon & Co shares in Q1 2023, an estimated $10.5M.
  • Norris Perne & French first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Norris Perne & French's Organon & Co position peaked at $16.9M in Q1 2022.
  • 768 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Norris Perne & French's 13F filing for Q1 2023, filed 20 Apr 2023.